Additionally, in the complex biological systems formed by CAFs within tumors, the dense ECM and elevated interstitial fluid pressure form physical barriers that prevent effective drug delivery to the tumor site, which make it difficult to target and deliver nanomedicines to CAFs. This evidence concerns the gene TBX1 and neoplasm.